Science Explorer Interactive view Map
Topic · Obstetrics and Gynecology

Uterine Myomas and Treatments

Uterine Myomas and Treatments is a research topic within Obstetrics and Gynecology. Science Explorer counts 34k research works in it since 1950. 12.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on various aspects of uterine conditions and their treatments, including uterine leiomyoma (fibroids), hysterectomy, uterine sarcomas, uterine artery embolization, reproductive outcomes after different treatments, MRI guidance for treatment, the role of progesterone, and the impact on health-related quality of life. The cluster also covers epidemiological studies related to uterine conditions.

  • Uterine Leiomyoma
  • Uterine Fibroids
  • Hysterectomy
  • Uterine Sarcomas
  • Uterine Artery Embolization
  • Reproductive Outcomes
  • MRI Guidance
  • Progesterone Action
  • Health-related Quality of Life
  • Epidemiology
Research works
34k
fractional, since 1950
In the world top 10%
4.4k
per year above
Top-10% rate
12.9%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+16%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Uterine Myomas and Treatments research?

By volume, the United States and China publish the most (1.3k and 848 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.3k works
  2. 2 China 848 works
  3. 3 India 581 works
  4. 4 Japan 296 works
  5. 5 Italy 249 works
  6. 6 United Kingdom 196 works
  7. 7 Türkiye 194 works
  8. 8 Germany 150 works
  9. 9 Russia 148 works
  10. 10 Spain 142 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.8%China: 20.6%India: 14.1%Japan: 7.2%6 others listed: 26.2%32%largest
United States1,306 · 31.8%China848 · 20.6%India581 · 14.1%Japan296 · 7.2%6 others listed1,078 · 26.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Uterine Myomas and Treatments research?

By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Uterine Myomas and Treatments research, followed by Obstetrics and Gynecology Hospital of Fudan University and Sichuan University.

By volume, 2022–2025

  1. 1 All India Institute of Medical SciencesIndia 27 works
  2. 2 Obstetrics and Gynecology Hospital of Fudan UniversityChina 26 works
  3. 3 Sichuan UniversityChina 25 works
  4. 4 Cleveland ClinicUnited States 22 works
  5. 5 Sağlık Bilimleri ÜniversitesiTürkiye 21 works
  6. 6 University of North Carolina at Chapel HillUnited States 21 works
  7. 7 Mayo Clinic in ArizonaUnited States 21 works
  8. 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 19 works
  9. 9 Institute of Medical SciencesIndia 18 works
  10. 10 Cedars-Sinai Medical CenterUnited States 18 works

Where is Uterine Myomas and Treatments research done?

The largest centres of Uterine Myomas and Treatments research in 2022–2025 are Beijing (China), Shanghai (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Scottsdale.

Largest cities, 2022–2025

  1. 1 Beijing China 100 works
  2. 2 Shanghai China 76 works
  3. 3 New York United States 76 works
  4. 4 Tokyo Japan 75 works
  5. 5 Seoul South Korea 75 works
  6. 6 London United Kingdom 69 works
  7. 7 Moscow Russia 69 works
  8. 8 Chengdu China 63 works
  9. 9 Istanbul Türkiye 62 works
  10. 10 New Delhi India 61 works

Where it is the local speciality

  1. ScottsdaleUS · 21.2 works7.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Uterine Myomas and Treatments than the world average.

See Uterine Myomas and Treatments on the map

Where is the best place to study Uterine Myomas and Treatments?

Among universities, judged by research, Baylor College of Medicine, Chongqing Medical University and Medical University of Lublin score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 16.68%fractional works in this node (log) →share in the world top 10% →Baylor College of Medicine: 17, 25.0%Chongqing Medical University: 17, 26.8%Medical University of Lublin: 12, 19.3%Institute of Medical Sciences: 18, 2.3%All India Institute of Medical Sciences: 26, 5.8%Jawaharlal Nehru Medical College: 14, 13.0%Sağlık Bilimleri Üniversitesi: 21, 7.5%University of Chicago: 17, 24.2%Johns Hopkins University: 15, 27.5%University of Toronto: 13, 15.4%Chongqing Medical Un…Baylor College of Me…Medical University o…Institute of Medical…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Baylor College of MedicineUnited States 55.625.0%7.2×17 +46.9%
2 Chongqing Medical UniversityChina 54.126.8%8.4×17 -26.1%
3 Medical University of LublinPoland 53.219.3%12.5×12 +55.5%
4 Institute of Medical SciencesIndia 50.92.3%9.6×18 +119.3%
5 All India Institute of Medical SciencesIndia 50.45.8%7.3×26 +85.8%
6 Jawaharlal Nehru Medical CollegeIndia 49.813.0%19.6×14 —
7 Sağlık Bilimleri ÜniversitesiTürkiye 45.77.5%6.3×21 —
8 University of ChicagoUnited States 44.924.2%3.5×17 +55.3%
9 Johns Hopkins UniversityUnited States 42.527.5%2.3×15 +43.1%
10 University of TorontoCanada 39.915.4%1.5×13 +216.1%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Uterine Myomas and Treatments research growing?

Output in 2018–2022 was 16% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Uterine Myomas and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.